Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Cited by (359)

Items 101–200 of 359

1. Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients
   Fredrik Nyberg, Atsushi Ogiwara, Chris G. Harbron, Takao Kawakami, Keiko Nagasaka, Sachiko Takami, Kazuya Wada, Hsiao-kun Tu, Makiko Otsuji, Yutaka Kyono et al. · 2011 · PLoS ONE
2. Therapeutic options for elderly patients with advanced non-small cell lung cancer
   Eric Joseph Avery, Anne Kessinger, Apar Kishor Ganti · 2009 · Cancer Treatment Reviews
3. Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study
   David Rossi, Donatella Dennetta, Marcello Ugolini, Paolo Alessandroni, Vincenzo Catalano, Stefano Fedeli, Paolo Giordani, Virginia Casadei, Anna Maria Baldelli, Francesco Graziano et al. · 2008 · Clinical Lung Cancer
4. Vinorelbine for non-small cell lung cancer
   Maria Carmela Piccirillo, Gennaro Daniele, Massimo Di Maïo, Jane Bryce, Gianfranco De Feo, Antonia Del Giudice, Francesco Perrone, Alessandro Morabito · 2010 · Expert Opinion on Drug Safety
5. nab -paclitaxel for the management of patients with advanced non-small-cell lung cancer
   Vera Hirsh · 2014 · Expert Review of Anticancer Therapy
6. Management of High-Risk Localized Prostate Cancer
   Ariel E. E. Marciscano, Matthew E. Hardee, Nicholas J Sanfilippo · 2011 · Advances in Urology
7. Older age, poor performance status and major comorbidities
   Charu Aggarwal, Corey Jay Langer · 2012 · Current Opinion in Oncology
8. Lung cancer and treatment in elderly patients: The Achilles Study
   Mariano Provencio, Carlos Camps, Vicente Alberola, B. Massutti, Núria Viñolas, Dolores Isla, Manuel Dómine, Isabel Millán, Manuel Cobo, Rafael Rosell · 2009 · Lung Cancer
9. Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients
   Toshio Kubo, Hiromi Watanabe, Kiichiro Ninomiya, Kenichiro Kudo, Daisuke Minami, Etsuko Murakami, Nobuaki Ochi, Takashi Ninomiya, Daijiro Harada, Masayuki Yasugi et al. · 2020 · Japanese Journal of Clinical Oncology
10. Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countries
    Hideki Maeda, Tatsuo Kurokawa · 2014 · Investigational New Drugs
11. Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Naruo Yoshimura, Shinzoh Kudoh, Tatsuo Kimura, Shigeki Mitsuoka, Shigenori Kyoh, Yoshihiro Tochino, Kazuhisa Asai, Toyoki Kodama, Yukikazu Ichimaru, Takashi Yana et al. · 2009 · Journal of Thoracic Oncology
12. Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007
    Nagio Takigawa, Katsuyuki Kiura, Yoshihiko Segawa, Katsuyuki Hotta, Akihiko Tamaoki, Yoshiyuki Tokuda, Takuya Nagata, Kazuhiko Watanabe, Kenichi Gemba, Tomonori Moritaka et al. · 2011 · Journal of Thoracic Oncology
13. Octogenarians with Advanced Non-small Cell Lung Cancer: Treatment Modalities, Survival, and Prognostic Factors
    Kuan‐Yu Chen, Jen‐Hau Chen, Jin‐Yuan Shih, Chih-Hsin Yang, Chong‐Jen Yu, Pan‐Chyr Yang · 2010 · Journal of Thoracic Oncology
14. Update on nonsmall cell lung cancer
    Gérard Zalcman, Emmanuel Bergot, Emmanuèle Lechapt · 2010 · European Respiratory Review
15. Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?
    Athanasios G. Pallis, Cesare Gridelli · 2010 · Cancer Treatment Reviews
16. Synthesis, characterization, and in vivo efficacy evaluation of PGG–docetaxel conjugate for potential cancer chemotherapy
    Sang Van, Yang, Shu, Danbo Yang, Ge Ge, Xin-guo Jiang, Jin Jin, Lei Yu · 2012 · International Journal of Nanomedicine
17. Management of Lung Cancer in the Elderly
    Archana Rao, Namita Sharma, Ajeet Gajra · 2016 · Cancer treatment and research
18. Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience
    Stefania Nobili, Daniele Lavacchi, Gabriele Perrone, Giulio Vicini, Renato Tassi, Ida Landini, Anna Maria Grosso, Giandomenico Roviello, Roberto Mazzanti, Carmine Santomaggio et al. · 2019 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
19. A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer
    Motohiro Tamiya, Akihiro Tamiya, Hiroyasu Kaneda, Kazuhiko Nakagawa, Kiyotaka Yoh, Kōichi Goto, Hiroaki Okamoto, Tsuneo Shimokawa, Tetsuya Abe, Hiroshi Tanaka et al. · 2015 · Medical Oncology
20. Therapeutic Landscape of Metastatic Non-Small-Cell Lung Cancer in Canada in 2020
    Arielle Elkrief, Philippe Joubert, Marie Florescu, Mustapha Ali Tehfe, Normand Blais, Bertrand Routy · 2020 · Current Oncology
21. Evaluation of Potential Interaction Between Vinorelbine and Clarithromycin
    Ryoichi Yano, Daisuke Tani, Kyohei Watanabe, Hitoshi Tsukamoto, Toshiaki Igarashi, Toshiaki Nakamura, Mikio Masada · 2009 · Annals of Pharmacotherapy
22. A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027
    Yuji Minegishi, Ou Yamaguchi, Shunichi Sugawara, Shoichi Kuyama, Satoshi Watanabe, Kazuhiro Usui, Masahide Mori, Osamu Hataji, Toshihiro Nukiwa, Satoshi Morita et al. · 2021 · BMC Cancer
23. Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
    Toshio Kawata, Mitsuo Higashimori, Yohji Itoh, Helen K. Tomkinson, Martin G. Johnson, Weifeng Tang, Fredrik Nyberg, Haiyi Jiang, Yusuke Tanigawara · 2019 · Cancer Chemotherapy and Pharmacology
24. Efficacy and safety of first-line erlotinib in elderly patients with advanced non-small cell lung cancer
    Ofer Merimsky, CHI-KIN CHENG, Joseph S. K. Au, Joachim von Pawel, Martin Reck · 2012 · Oncology Reports
25. Detection and Characterization of Sentinel Lymph Node by Ultrasound Molecular Imaging with B7-H3-Targeted Microbubbles in Orthotopic Breast Cancer Model in Mice
    Zhongqian Hu, Sunitha V. Bachawal, Xuelin Li, Huaijun Wang, Katheryne E. Wilson, Pan Li, Ramasamy Paulmurugan · 2021 · Molecular Imaging and Biology
26. Customized chemotherapy based on epidermal growth factor receptormutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
    Shiro Fujita, Nobuyuki Katakami, Katsuhiro Masago, Hiroshige Yoshioka, Keisuke Tomii, Toshihiko Kaneda, Masataka Hirabayashi, Kei Kunimasa, Toshio Morizane, Tadashi Mio · 2012 · BMC Cancer
27. Management of unfit older patients with advanced NSCLC
    Cesare Gridelli, Paolo Maione, Antônio Rossi, Giovanni Palazzolo, Giuseppe Colantuoni, Emanuela Rossi · 2009 · Cancer Treatment Reviews
28. Distinctive impact of pre-existing interstitial lung disease on the risk of chemotherapy-related lung injury in patients with lung cancer
    Yuichi Ozawa, Daisuke Akahori, Keigo Koda, Takefumi Abe, Hirotsugu Hasegawa, Takashi Matsui, Masayuki Tanahashi, Hiroshi Niwa, Kazunari Yamada, Koshi Yokomura et al. · 2016 · Cancer Chemotherapy and Pharmacology
29. Optimizing Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer
    Giorgio V. Scagliotti · 2007 · Journal of Thoracic Oncology
30. Optimal Pharmacotherapeutic Strategies for Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Élisabeth Quoix · 2011 · Drugs & Aging
31. Treatment of advanced non-small cell lung cancer in the elderly
    Paola Claudia Sacco, Paolo Maione, Giovanni Palazzolo, Cesare Gridelli · 2018 · Expert Review of Respiratory Medicine
32. Low-Dose Weekly Docetaxel Is as Tolerable as Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer
    Fu‐Tsai Chung, Kang-Yun Lee, Yueh‐Fu Fang, Meng-Heng Shieh, Shu‐Min Lin, Chih-Teng Yu, Yun Lun Lo, Ting‐Yu Lin, Chih-Hsi Scott Kuo, Po‐Hao Feng et al. · 2011 · Chemotherapy
33. Impact of docetaxel plus ramucirumab on metastatic site in previously treated patients with non-small cell lung cancer: a multicenter retrospective study
    Kinnosuke Matsumoto, Akihiro Tamiya, Yoshinobu Matsuda, Yoshihiko Taniguchi, Shinji Atagi, Hayato Kawachi, Motohiro Tamiya, Satoshi Tanizaki, Junji Uchida, Kiyonobu Ueno et al. · 2021 · Translational Lung Cancer Research
34. Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901
    Young Hak Kim, Masataka Hirabayashi, Shinji Kosaka, Junichi Nikaidoh, Yasumichi Yamamoto, Masatoshi Shimada, Toshiya Toyazaki, Hiroki Nagai, Yuichi Sakamori, Michiaki Mishima · 2013 · Cancer Chemotherapy and Pharmacology
35. Phase II Study of Gefitinib as a First-line Therapy in Elderly Patients with Pulmonary Adenocarcinoma: West Japan Thoracic Oncology Group Study 0402
    Masashi Kobayashi, Koji Matsui, Nobuyuki Katakami, K. Takeda, Azusa Moriyama, Y. Iwamoto, M Takada, Hiroshige Yoshioka, Naoko Sueoka‐Aragane, Kazuhiko Nakagawa et al. · 2011 · Japanese Journal of Clinical Oncology
36. Chemotherapy in elderly patients with nonsmall cell lung cancer
    Rajwanth R. Veluswamy, Benjamin Philip Levy, Juan P. Wisnivesky · 2016 · Current Opinion in Pulmonary Medicine
37. The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer
    Suresh S. Ramalingam, Fadlo Raja Khuri · 2009 · The Oncologist
38. Durvalumab in frail and elderly patients with stage four non-small cell lung cancer: Study protocol of the randomized phase II DURATION trial
    Jonas Kuon, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Albrecht Stenzinger, Miriam Blasi, Farastuk Bozorgmehr, Martin Maenz, Meinhard Kieser, Marc Andre Schneider et al. · 2020 · Trials
39. Evaluation and Management of Elderly Patients With Lung Cancer
    Elizabeth Gore, Benjamin Movsas, Rafael Santana-Dávila, Corey Jay Langer · 2012 · Seminars in Radiation Oncology
40. Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
    Athanasios Karampeazis, Lambros N. Vamvakas, Athanasios Panayotis Kotsakis, Charalambos Christophyllakis, Nikolaos K. Kentepozidis, Vassilios Chandrinos, Anna Agelidou, Aris Polyzos, Xanthi Tsiafaki, Dora Hatzidaki et al. · 2016 · Journal of Geriatric Oncology
41. The effects of advanced age and serum α1‐acid glycoprotein on docetaxel unbound exposure and dose‐limiting toxicity in cancer patients
    Hirotsugu Kenmotsu, Chiyo K. Imamura, Akira Ono, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Tetsuhiko Taira, Tateaki Naito, Haruyasu Murakami, Toshiaki Takahashi et al. · 2017 · British Journal of Clinical Pharmacology
42. A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer
    Francisco Robert, Karen Harper, Judie Ackerman, Sunil Gupta · 2009 · Cancer Chemotherapy and Pharmacology
43. Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1
    Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki, Kosuke Hamai, Naoko Matsumoto, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Mineyo Mito, Kakuhiro Yamaguchi et al. · 2022 · Thoracic Cancer
44. A comparative study on the effect of docetaxel-albumin nanoparticles and docetaxel-loaded PEG-albumin nanoparticles against non-small cell lung cancer
    GUANGMING JIN, Mingji Jin, XUEZHE YIN, Zhehu Jin, Liqing Chen, Zhonggao Gao · 2015 · International Journal of Oncology
45. A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Takashi Kasai, Yoichi Nakamura, Minoru Fukuda, Takeshi Kitazaki, Seiji Nagashima, Hiroshi Takatani, Hirofumi Nakano, Katsumi Nakatomi, Takaya Ikeda, Hiroyuki Yamaguchi et al. · 2015 · Chemotherapy
46. The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer
    Tadashi Sakaguchi, Naoki Furuya, Kentaro Ito, Naoya Hida, Kei Morikawa, Yuko Komase, Takeo Inoue, Osamu Hataji, Masamichi Mineshita · 2020 · Thoracic Cancer
47. Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment
    Akira Nakao, Osamu Hiranuma, Junji Uchino, Chikara Sakaguchi, Tomoyuki Araya, Noriya Hiraoka, Tamotsu Ishizuka, Takayuki Takeda, Masayuki Kawasaki, Yasuhiro Gotô et al. · 2020 · Journal of Clinical Medicine
48. Therapeutic Applications of Nitric Oxide for Malignant Tumor in Animal Models and Human Studies
    Hiroyasu Yasuda, Kazuhiro Yanagihara, Katsutoshi Nakayama, Tadashi Mio, Takahiko Sasaki, Masanori Asada, Mutsuo Yamaya, Masanori Fukushima · 2010 · Springer eBooks
49. A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer
    Yusuke Okuma, Yukio Hosomi, Satoshi Takahashi, Yoshiro Nakahara, Kageaki Watanabe, Makoto Nagamata, Yusuke Takagi, Shinichiro Mikura · 2016 · Cancer Chemotherapy and Pharmacology
50. Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
    Hisatsugu Goto, Yoshio Okano, Hisanori Machida, Nobuo Hatakeyama, Fumitaka Ogushi, Takashi Haku, Takanori Kanematsu, Tomoyuki Urata, Soji Kakiuchi, Masaki Hanibuchi et al. · 2017 · Respiratory Investigation
51. The Treatment of Advanced Lung Cancer in the Elderly
    Carolyn Jean Presley, Rogério Lilenbaum · 2015 · The Cancer Journal
52. Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer
    Joung-Soon Jang, Hoon-Kyo Kim, Byoung Chul Cho, Kyung Hee Lee, Hwan‐Jung Yun, In Sook Woo, HONG SUK SONG, Hun Mo Ryoo, Chi-Hong Kim, Der-Sheng Sun et al. · 2017 · Cancer Chemotherapy and Pharmacology
53. First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data
    Shoko Noda‐Narita, Asuka Kawachi, Ayako Okuyama, Ryo Sadachi, Akihiro Hirakawa, Yasushi Goto, Yasuhiro Fujiwara, Takahiro Higashi, Kan Yonemori · 2021 · PLoS ONE
54. A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer
    Noboru Yamamoto, Tomohide Tamura, Takayasu Kurata, Nobuyuki Yamamoto, Ikuo Sekine, Hideo Kunitoh, Yuichiro Ohe, Nagahiro Saijo · 2009 · Cancer Chemotherapy and Pharmacology
55. An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment
    Orazio Caffo, Mariachiara Dipasquale, Viviana Murgia, Antonello Veccia, Enzo Galligioni · 2013 · Expert Opinion on Drug Metabolism & Toxicology
56. A phase II study of combination chemotherapy with docetaxel and carboplatin for elderly patients with advanced non-small cell lung cancer
    Hye Jin Kim, Tae Gyoon Kim, Hyun Jeong Lee, Jee Ho Kim, Byung Hoon Lim, Jae Won Seo, Eun Mi Kang, Byung Uk Lee, Young Mi Ahn, Yong Ho Roh et al. · 2009 · Lung Cancer
57. Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer
    Shirish M. Gadgeel, Antoinette J. Wozniak, John C. Ruckdeschel, Lance K. Heilbrun, Raghu Venkatramanamoorthy, Ruth Chaplen, Michael Kraut, Gregory Peter Kalemkerian · 2008 · Journal of Thoracic Oncology
58. NSCLC in the Elderly—The Legacy of Therapeutic Neglect
    Jared M. Weiss, Corey Jay Langer · 2009 · Current Treatment Options in Oncology
59. Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer
    Chia‐Chi Lin, Chih-Hsin Yang · 2009 · Targeted Oncology
60. Radiotherapy for Stage III Non–Small-Cell Lung Carcinoma in the Elderly (Age ≥ 70 years)
    Paul D. Aridgides, Adam Janik, Jeffrey A. Bogart, Steven Duffy, Paula F. Rosenbaum, Ajeet Gajra · 2013 · Clinical Lung Cancer
61. Current challenges of lung cancer care in an aging population
    Paola Claudia Sacco, Francesca Casaluce, Assunta Sgambato, Antônio Rossi, Paolo Maione, Giovanni Palazzolo, Alba Napolitano, Cesare Gridelli · 2015 · Expert Review of Anticancer Therapy
62. A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol
    Yoshihito Kogure, Hideo Saka, Yuichi Takiguchi, Shinji Atagi, Takayasu Kurata, Noriyuki Ebi, Akira Inoue, Kaoru Kubota, Mitsuhiro Takenoyama, Takashi Seto et al. · 2018 · Clinical Lung Cancer
63. Outcomes and Tolerability of Systemic Chemotherapy for Pancreatic or Biliary Cancer Patients Aged 75 Years or Older
    Seigo Yukisawa, Hiroshi Ishii, Masato Matsuyama, K. Kuraoka, K Takano, A. Kamei, Masato Ozaka · 2010 · Japanese Journal of Clinical Oncology
64. A Phase II Study of Pemetrexed in Chemotherapy-naive Elderly Patients Aged >=75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003)
    Y. Hattori, Masahiro Iwasaku, Miyako Satouchi, Akihiro Nishiyama, Y. Korogi, Kojiro Otsuka, Shiro Fujita, Nobuyuki Katakami, M. Mori, Kazumi Nishino et al. · 2013 · Japanese Journal of Clinical Oncology
65. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer
    Guangming Jin, Mingji Jin, Zhehu Jin, Zhonggao Gao, Xuezhe Yin · 2016 · Oncology Reports
66. Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502
    Takashi Seto, Takeharu Yamanaka, Izumi Wasada, Nobuhiko Seki, Hiroaki Okamoto, Takashi Ogura, Masahiko Shibuya, Yuichi Takiguchi, Tetsu Shinkai, Noriyuki Masuda et al. · 2010 · Lung Cancer
67. Therapeutic options in older patients with metastatic non-small cell lung cancer
    Élisabeth Quoix · 2012 · Therapeutic Advances in Medical Oncology
68. Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience
    Yuka Kato, Katsuyuki Hotta, Nagio Takigawa, Naoyuki Nogami, Toshiyuki Kozuki, Akiko Satô, Eiki Ichihara, Kenichiro Kudo, Isao Oze, Masahiro Tabata et al. · 2014 · Cancer Chemotherapy and Pharmacology
69. Challenges treating older non-small cell lung cancer patients
    Cesare Gridelli, Antônio Rossi, Paolo Maione · 2008 · Annals of Oncology
70. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non–Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group
    Athanasios Karampeazis, Lambros N. Vamvakas, Nikolaos K. Kentepozidis, Aris Polyzos, Vassilis Chandrinos, George Rigas, Charalambos Christophyllakis, Athanasios Panayotis Kotsakis, Dora Hatzidaki, Athanasios G. Pallis et al. · 2016 · Clinical Lung Cancer
71. The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update
    Alexios Matikas, Vassilis Georgoulias, Athanasios Panayotis Kotsakis · 2016 · Expert Review of Respiratory Medicine
72. Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type
    Fumihiko Hirai, Makoto Edagawa, Shinichiro Shimamatsu, Ryo Toyozawa, Gouji Toyokawa, Kaname Nosaki, Masafumi Yamaguchi, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose · 2017 · Oncology Letters
73. Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness
    Alicia Ruelaz Maher, Isomi M Miake-Lye, Jessica M Beroes, Paul Shekelle · 2012 · Europe PMC (PubMed Central)
74. Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan
    Tomoya Kawaguchi, Akihiro Tamiya, Atsuhisa Tamura, Masamichi Arao, Ryusei Saito, Akihide Matsumura, Sai‐Hong Ignatius Ou, Taro Tamura · 2012 · Clinical Lung Cancer
75. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study
    Jaime Feliú, J. L. Fírvida, Javier Castro, Catherina Madroñal, A. Rodríguez-Jaráiz, Mercedes Salgado, Cristóbal Belda-Iniesta, Enrique Casado, Jesús García-Mata, Manuel González-Barón et al. · 2008 · Cancer Chemotherapy and Pharmacology
76. Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy
    William N. William, Fadlo Raja Khuri, Frank V. Fossella, Bonnie S. Glisson, Ralph Zinner, J Jack Lee, Roy S. Herbst, Scott Michael Lippman, Edward S. Kim · 2010 · American Journal of Clinical Oncology
77. Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
    Rolof G.P. Gijtenbeek, Kim de Jong, Ben J.W. Venmans, Femke H. M. van Vollenhoven, Anneke Ten Brinke, Anthonie J. van der Wekken, Wouter Heero van Geffen · 2023 · Cochrane Database of Systematic Reviews
78. Alternate‑day administration of S‑1 for elderly patients with advanced non‑small‑cell lung carcinoma: A prospective feasibility study
    Takeshi Masuda, Masako Watanabe, Kazunori Fujitaka, Kosuke Hamai, Nobuhisa Ishikawa, Mihoko Doi, Soichi Kitaguchi, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu et al. · 2018 · Molecular and Clinical Oncology
79. Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer
    Reiko Yoshino, Hisao Imai, Keita P. Mori, Yoshio Tomizawa, Kosuke Takei, Mai Tomizawa, Kyoichi Kaira, Akihiro Yoshii, Satoru Watanabe, Ryusei Saito et al. · 2015 · Journal of Cancer Research and Therapeutics
80. Management of non-small-cell lung cancer in the older adult
    Ari M. Vanderwalde, Sumanta Kumar Pal, Karen L. Reckamp · 2011 · Maturitas
81. Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)
    Akito Hata, Nobuyuki Katakami, Yoshihiro Hattori, Kosuke Tanaka, Shiro Fujita, Yoshikazu Kotani, Takashi Nishimura, Fumio Imamura, Soichiro Yokota, Miyako Satouchi et al. · 2017 · Cancer Chemotherapy and Pharmacology
82. Efficacy and safety of S ‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis
    Hisao Imai, Hiroyuki Minemura, Takayuki Kishikawa, Yutaka Yamada, Kensuke Suzuki, Yukihiro Umeda, Satoshi Wasamoto, Norimitsu Kasahara, Shinichi Ishihara, Ou Yamaguchi et al. · 2020 · Thoracic Cancer
83. First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study
    Ke-qi Han, Weiguo Cao, Jinfeng Che, Shenxu Bo, Xiaodong Guo, Guang Huang, Lijun Ma, Sun Liangqi, Chunfang Gao, Bao‐Liang Zhong et al. · 2009 · Journal of Thoracic Oncology
84. Advanced Non–Small-Cell Lung Cancer in the Elderly
    Lambros N. Vamvakas, Emmanouil S. Saloustros, Athanasios Karampeazis, Vassilis Georgoulias · 2009 · Clinical Lung Cancer
85. Practice pearls in the management of lung cancer in the elderly
    Ravindran Kanesvaran, Anupama Roy Chowdhury, Lalit Kumar Radha Krishna · 2016 · Journal of Geriatric Oncology
86. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Koichi Takayama, Masao Ichiki, Takemasa Matsumoto, Noriyuki Ebi, Shinji Akamine, Shoji Tokunaga, Tadaaki Yamada, Junji Uchino, Yoichi Nakanishi · 2019 · The Oncologist
87. Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study
    Ioannis Boukovinas, John Souglakos, Dora Hatzidaki, Stelios Kakolyris, Nikolaos Ziras, L. Vamvakas, Aris Polyzos, A. Geroyianni, Athina Agelidou, Sofia Agelaki et al. · 2008 · Lung Cancer
88. Möglichkeiten und Grenzen der onkologischen Chemotherapie bei alten Patienten
    Ulrich Wedding · 2010 · Der Internist
89. Treatment rationale and design of the SPIRAL study
    Junji Uchino, Akira Nakao, Nobuyo Tamiya, Yoshiko Kaneko, Tadaaki Yamada, Kenichi Yoshimura, Masaki Fujita, Koichi Takayama · 2018 · Medicine
90. Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A)
    Hiroshi G. Katayama, Junki Mizusawa, Haruhiko Fukuda, Shinichiro Nakamura, K. Nakamura, Nagahiro Saijo, Akira Yokoyama, Y. Ohe, Tetsu Shinkai, Kazuhiko Nakagawa et al. · 2021 · Japanese Journal of Clinical Oncology
91. Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study
    Satoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, Hayato Kawachi, Motohiro Tamiya, Takafumi Yanase et al. · 2023 · European Journal of Clinical Pharmacology
92. Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study
    Hideki Kusagaya, Naoki Inui, Masato Karayama, Yutaro Nakamura, Shigeki Kuroishi, Koshi Yokomura, Mikio Toyoshima, Toshihiro Shirai, Masafumi Masuda, Takashi Yamada et al. · 2012 · Lung Cancer
93. Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor
    Kaoru Irisa, Katsuhiro Masago, Yosuke Togashi, Shiro Fujita, Yukimasa Hatachi, Akiko Fukuhara, Yuichi Sakamori, Yung Hak Kim, Tadashi Mio, Michiaki Mishima · 2010 · Medical Oncology
94. First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study
    Carmelo Tibaldi, Enrico Vasile, Andrea Antonuzzo, Roberta Di Marsico, A Fabbri, Florio Innocenti, Gianna Tartarelli, DOMENICO AMOROSO, Michele Andreuccetti, Monica Lo Dico et al. · 2008 · British Journal of Cancer
95. Treatment of Advanced Lung Cancer in the Elderly
    Ajeet Gajra, Stuart M. Lichtman · 2011 · Hospital Practice
96. Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinoma
    Xia Liu, Guopeng Jiang, Xuefei Sun, Guangfeng Su, Xuan Zhang, Dan Shen, Na Yan · 2023 · Frontiers in Oncology
97. A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer
    Hiroyuki Minemura, Hiroshi Yokouchi, K. Azuma, Ken-ichiro Hirai, Satoko Sekine, Kengo Oshima, Kenya Kanazawa, Yoshinori Tanino, Yayoi Inokoshi, Taeko Ishii et al. · 2015 · BMC Research Notes
98. Treatment of elderly patients with stage IV non-small-cell lung cancer
    Jared M. Weiss, Thomas E. Stinchcombe · 2011 · Expert Review of Anticancer Therapy
99. Clinicopathologic Factors Affecting the Progression-Free Survival of Patients With Advanced Non–Small-Cell Lung Cancer After Gefitinib Therapy
    Katsuhiro Masago, Shiro Fujita, Yosuke Togashi, Young Hak Kim, Yukimasa Hatachi, Akiko Fukuhara, Hiroki Nagai, Yuichi Sakamori, Tadashi Mio, Michiaki Mishima · 2011 · Clinical Lung Cancer
100. Evaluation of the Efficacy and Safety of the Combination of Gemcitabine and Nedaplatin for Elderly Patients with Advanced Non-Small-Cell Lung Cancer
     T. Sugiyama, Takashi Hirose, Masanao Nakashima, Koko Ishida, Yasunari Oki, Yasunori Murata, S Kusumoto, Tsuyoshi Shirai, Toshimitsu Yamaoka, Kensuke Okuda et al. · 2011 · Oncology